TGFB1 and central nervous system cancer: A downregulation of NKG2D ligands (such as MICA/B, ULBPs) along with secretion of immunosuppressive factors (like TGF-β, PGE2) from glioma cells has been shown to block the cytotoxic function of NK cells [122].